HRP980231B1 - Phosphodiesterase 4 - inhibiting diazepinoindolones - Google Patents
Phosphodiesterase 4 - inhibiting diazepinoindolonesInfo
- Publication number
- HRP980231B1 HRP980231B1 HR980231A HRP980231A HRP980231B1 HR P980231 B1 HRP980231 B1 HR P980231B1 HR 980231 A HR980231 A HR 980231A HR P980231 A HRP980231 A HR P980231A HR P980231 B1 HRP980231 B1 HR P980231B1
- Authority
- HR
- Croatia
- Prior art keywords
- formula
- compounds
- phosphodiesterase
- diazepinoindolones
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9705422A FR2762841B1 (fr) | 1997-04-30 | 1997-04-30 | Diazepino-indolones inhibitrices de phosphodiesterases iv |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP980231A2 HRP980231A2 (en) | 2000-04-30 |
HRP980231B1 true HRP980231B1 (en) | 2002-06-30 |
Family
ID=9506517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR980231A HRP980231B1 (en) | 1997-04-30 | 1998-04-29 | Phosphodiesterase 4 - inhibiting diazepinoindolones |
Country Status (17)
Country | Link |
---|---|
US (1) | US6239130B1 (ja) |
EP (1) | EP0980374B1 (ja) |
JP (1) | JP2001522367A (ja) |
KR (1) | KR20010020386A (ja) |
AT (1) | ATE232534T1 (ja) |
AU (1) | AU729495B2 (ja) |
BR (1) | BR9809429A (ja) |
CA (1) | CA2278217A1 (ja) |
DE (1) | DE69811360T2 (ja) |
DK (1) | DK0980374T3 (ja) |
ES (1) | ES2190083T3 (ja) |
FR (1) | FR2762841B1 (ja) |
HR (1) | HRP980231B1 (ja) |
MX (1) | MXPA99006979A (ja) |
NZ (1) | NZ337589A (ja) |
WO (1) | WO1998049169A1 (ja) |
ZA (1) | ZA983704B (ja) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2795731B1 (fr) * | 1999-07-02 | 2001-09-07 | Warner Lambert Co | PROCEDE DE PREPARATION DE [1,4] DIAZEPINO [6,7,1-hi] INDOL-4-ONES SUBSTITUEES |
WO2001064669A1 (en) * | 2000-03-03 | 2001-09-07 | Pfizer Products Inc. | Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
EP1161949A1 (en) | 2000-06-09 | 2001-12-12 | Warner-Lambert Company | Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease |
EP1199074A1 (en) * | 2000-09-15 | 2002-04-24 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
EP1188438A1 (en) * | 2000-09-15 | 2002-03-20 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production |
ES2427930T3 (es) | 2001-05-23 | 2013-11-04 | Mitsubishi Tanabe Pharma Corporation | Composición terapéutica para el tratamiento regenerativo de enfermedades de los cartílagos |
WO2002094321A1 (fr) | 2001-05-23 | 2002-11-28 | Tanabe Seiyaku Co., Ltd. | Compositions favorisant la guérison d'une fracture osseuse |
AU2002317377A1 (en) * | 2001-07-20 | 2003-03-03 | Cancer Research Technology Limited | Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer |
MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
US20050187278A1 (en) * | 2003-08-28 | 2005-08-25 | Pharmacia Corporation | Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors |
WO2006073413A1 (en) * | 2004-02-20 | 2006-07-13 | The Board Of Trustees Of The University Of Illinois | Blood pressure reduction in salt-sensitive |
WO2005102317A1 (en) * | 2004-04-23 | 2005-11-03 | Celgene Corporation | Methods of using and compositions comprising pde4 modulators for the treatment and management of pulmonary hypertension |
MX2007012711A (es) * | 2005-04-19 | 2008-01-11 | Nycomed Gmbh | Roflumilast para el tratamiento de hipertension pulmonar. |
WO2008041118A2 (en) * | 2006-10-04 | 2008-04-10 | Pfizer Products Inc. | Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
US20090182035A1 (en) * | 2007-04-11 | 2009-07-16 | Alcon Research, Ltd. | Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis |
CA2682730A1 (en) * | 2007-04-11 | 2008-10-23 | Alcon Research, Ltd. | Use of an inhibitor of tnf.alpha. plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis |
MX2009013990A (es) * | 2007-06-26 | 2010-03-30 | Lexicon Pharmaceuticals Inc | Metodos para tratar enfermedades y trastornos mediados por serotonina. |
BR112012007091A2 (pt) * | 2009-10-01 | 2016-04-19 | Alcon Res Ltd | composições de olopatadina e seus usos |
CN113423435A (zh) | 2018-12-28 | 2021-09-21 | 雷杰纳荣制药公司 | 使用花生四烯酸15-脂氧合酶(alox15)抑制剂治疗呼吸系统病症 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2725719B1 (fr) * | 1994-10-14 | 1996-12-06 | Jouveinal Inst Rech | Diazepino-indoles inhibiteurs de phosphodiesterases iv |
-
1997
- 1997-04-30 FR FR9705422A patent/FR2762841B1/fr not_active Expired - Fee Related
-
1998
- 1998-04-29 HR HR980231A patent/HRP980231B1/xx not_active IP Right Cessation
- 1998-04-30 CA CA002278217A patent/CA2278217A1/en not_active Abandoned
- 1998-04-30 MX MXPA99006979A patent/MXPA99006979A/es unknown
- 1998-04-30 ZA ZA9803704A patent/ZA983704B/xx unknown
- 1998-04-30 KR KR1019997010008A patent/KR20010020386A/ko not_active Application Discontinuation
- 1998-04-30 AU AU77652/98A patent/AU729495B2/en not_active Ceased
- 1998-04-30 US US09/380,883 patent/US6239130B1/en not_active Expired - Fee Related
- 1998-04-30 DE DE69811360T patent/DE69811360T2/de not_active Expired - Fee Related
- 1998-04-30 JP JP54662498A patent/JP2001522367A/ja not_active Abandoned
- 1998-04-30 EP EP98925598A patent/EP0980374B1/en not_active Expired - Lifetime
- 1998-04-30 NZ NZ337589A patent/NZ337589A/xx unknown
- 1998-04-30 AT AT98925598T patent/ATE232534T1/de not_active IP Right Cessation
- 1998-04-30 DK DK98925598T patent/DK0980374T3/da active
- 1998-04-30 WO PCT/EP1998/002827 patent/WO1998049169A1/en not_active Application Discontinuation
- 1998-04-30 BR BR9809429-7A patent/BR9809429A/pt not_active IP Right Cessation
- 1998-04-30 ES ES98925598T patent/ES2190083T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FR2762841B1 (fr) | 1999-07-02 |
US6239130B1 (en) | 2001-05-29 |
NZ337589A (en) | 2000-10-27 |
FR2762841A1 (fr) | 1998-11-06 |
AU7765298A (en) | 1998-11-24 |
EP0980374A1 (en) | 2000-02-23 |
CA2278217A1 (en) | 1998-11-05 |
AU729495B2 (en) | 2001-02-01 |
DE69811360D1 (de) | 2003-03-20 |
BR9809429A (pt) | 2000-06-13 |
EP0980374B1 (en) | 2003-02-12 |
ZA983704B (en) | 1999-10-25 |
ATE232534T1 (de) | 2003-02-15 |
KR20010020386A (ko) | 2001-03-15 |
DE69811360T2 (de) | 2003-10-09 |
ES2190083T3 (es) | 2003-07-16 |
DK0980374T3 (da) | 2003-05-05 |
MXPA99006979A (es) | 2005-04-19 |
JP2001522367A (ja) | 2001-11-13 |
HRP980231A2 (en) | 2000-04-30 |
WO1998049169A1 (en) | 1998-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP980231B1 (en) | Phosphodiesterase 4 - inhibiting diazepinoindolones | |
PL314605A1 (en) | Isoxazolin compounds as anti-inflammatory agents | |
GR3032506T3 (en) | 3-aryl-2-isoxazolines as antiinflammatory agents | |
MX9606546A (es) | Compuestos inhibidores de la enzima conversiva de interleukina-1 beta. | |
WO1997022619A3 (en) | INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME | |
BG104138A (en) | 2-aminopyridines containing substituents with condensed rings as nos inhibitors | |
MY122278A (en) | 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position | |
AP2000001992A0 (en) | Succinamide inhibitors of inteleukin-1B converting enzyme. | |
IL117209A (en) | 1-aryl-2-acylamino-ethane compounds and pharmaceutical compositions containing them | |
BG104292A (en) | Methods and compositions for the treatment of rheumatoid arthritis | |
PL358552A1 (en) | 2-aminoalkyl-thieno[2,3-d]pyrimidines | |
BG104373A (en) | Polymorphous forms of dofetilide | |
MX9805015A (es) | INHIBIDORES DE LA ENZIMA QUE CONVIERTE LA INTERLEUCINA-1 beta. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20040429 Year of fee payment: 7 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20050430 |